Zhejiang Huadong Pharmaceutical

Huadong Medicine is a leading Chinese pharmaceutical company headquartered in Hangzhou, specializing in the R&D, manufacturing, and distribution of pharmaceutical products. The company focuses on core therapeutic areas including oncology, immunology, nephrology, and endocrinology, with a significant and growing presence in the medical aesthetics market. Huadong has transitioned from a generic-heavy portfolio to an innovation-driven pipeline, notably through strategic global partnerships and acquisitions in the ADC and GLP-1 spaces. Its commercial operations span the entire value chain, from active pharmaceutical ingredients (APIs) to finished dosages and a large-scale domestic distribution network.